SREBF1 and metabolic dysfunction-associated steatotic liver disease: In both the HFD and MCD-induced MASLD mice models, the expression of hepatic lipogenesis genes SREBP1 and the glucose transporter (GLUT9) expression were significantly downregulated for attenuating MASLD symptoms after knockouting GLUT9 in liver [53].